Reported by: FX Hanon,
DPharm, JS Spika, MD, MN Mulders, PhD, G Lipskaya, PhD, N Emiroglu, MD, World Health Organization, Regional Office for Europe, Copenhagen, Denmark.
to design and install the system, which will include a high-capacity DPharm unit to fill source vessels quickly, along with companion nuclear radiation containment chambers, or "hot cells."
Source vessels are then filled with a Mo-99 solution using the DPharm and then shipped to customers for use with the RadioGenix isotope separation system.